§ Funding Round
Series D funding round for Atea Pharmaceuticals raising $220M in May 2020
Series D funding round for Atea Pharmaceuticals raising $220M in May 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Ally Bridge Group | — | — |
| Organization | — | |
Morningside Ventures | — | — |
Omega Funds | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
T. Rowe Price Associates | — | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$220M
Top Valuation
-
Atea Pharmaceuticals raised $220M in a Series D round.
The round was announced on 05/01/20.
The round was led by Bain Capital Life Sciences.
